Study: Americans who received Johnson & Johnson coronavirus vaccine have more than TRIPLE the risk of blood clotsA study published in the journal JAMA Internal Medicine found that Americans who received Johnson & Johnson’s (J&J) Wuhan coronavirus (COVID-19) vaccine have a higher risk of developing blood clotting conditions than the general population. Findings showed that women are also more likely to develop blood clotting.
For the study, scientists from the Mayo Clinic in Rochester, Minnesota, compared data from the general population before the pandemic to data gathered from reported vaccine side effects experienced by American citizens after inoculation.
Findings revealed that those given the J&J COVID-19 vaccine was at least 3.5 times as likely to develop brain blood clots compared to an average person before the pandemic.
Cerebral venous sinus thrombosis and stroke risk
Blood clotting, particularly cerebral venous sinus thrombosis (CVST), is a common side effect of the J&J COVID-19 vaccine. But despite the health risks of the J&J COVID-19 vaccine, the scientists claim that the risk is rare and that the findings should still be considered in the context of the effectiveness of the vaccine in preventing severe cases of the infectious disease.
For the study, the scientists harvested data from Olmstead County, Minnesota, which had a population of at least 158,000 people and is located 90 miles southeast of Minneapolis. The data gathered was from 2001 to 2015. During the 14-year period, there were 39 residents who developed CVST, a rare and potentially deadly blood clotting condition that can form in the brain...
-- excerpt, rest at link above --
